Medicine shortages
Our work to highlight how medicine shortages affect patient care, the pressures on pharmacy teams, and recommendations to inform action.


World Patient Safety Day (WPSD) 2026
This year’s World Patient Safety Day theme focuses on safe and effective care for people living with noncommunicable diseases (NCDs), under the slogan ‘Safe care for life!’.

RCPharm annual conference 2026
Bringing together pharmacists and pharmaceutical scientists from across the UK and beyond, this will be our first Annual Conference as the new Royal College.
News
The latest news and updates from Royal College of Pharmacy.
-
Royal Colleges call for review of propranolol safety information
Patient safety concerns over use of the medicine propranolol for generalised anxiety have prompted leading experts to call for a review of the medicine's safety information, particularly around overdose, self-harm and suicide risk. The Royal College of Pharmacy and the Royal College of Physicians Medicines Safety Joint Working Group, in collaboration with the National Poisons Information Service, has written to the Medicines and Healthcare products Regulatory Agency (MHRA) requesting updates to the medicine’s Summary of Product Characteristics. The request is based on evidence and clinical experience which indicate that the current licensed indication for propranolol in generalised anxiety is problematic for a number of reasons: There is no proven evidence that propranolol is effective in the treatment of generalised anxiety disorder. Propranolol poisoning is life-threatening, difficult to treat and is associated with a significant number of deaths. Prescribing for propranolol in general practice is increasing*, partly because the medicine is perceived to be relatively safe. Patients at increased risk of overdose, including those taking antidepressants or with a history of overdose, continue to be prescribed propranolol. The letter to the MHRA is part of a wider programme of activity led by the Royal College of Pharmacy (RCPharm) and Royal College of Physicians (RCP) Medicines Safety Joint Working Group to improve understanding of medication-related risks and support safer prescribing across the healthcare system. Kate Ryan, Joint Chair of the RCP/RCPharm Medicines Safety Joint Working Group, said: "Patient safety is at the heart of this work. While propranolol remains an effective treatment for many patients, its use for anxiety presents challenges. We are concerned about the serious consequences of overdose, particularly for vulnerable individuals." Dr Zuzanna Sawicka, Joint Chair of the RCP/RCPharm Medicines Safety Joint Working Group, said: "We are asking the MHRA to review whether the current indication for generalised anxiety disorder and associated safety information remain appropriate. Strengthening awareness of these risks among healthcare professionals and patients could support safer prescribing decisions and help prevent avoidable harm." The joint Medicines Safety Group will also be supporting an NHS England Patient Safety Team short-life working group examining this issue, including consideration of non-pharmacological and supported self-care options for patients. Today is World Patient Safety Day; explore our resources to support patient safety. Read more news stories.
-
Royal College of Pharmacy updates guide for chief pharmacists to support pharmacy leaders
The Royal College of Pharmacy (RCPharm) has updated its guide for chief pharmacists, directors of pharmacy and senior pharmacy leaders. The new guide for chief pharmacists or equivalent is a practical reference and signposting resource that reflects the significant changes in healthcare policy, pharmacy legislation and service delivery since it was originally developed in 2017. It also provides updates on the evolving responsibilities of pharmacy leaders across England, Scotland and Wales. The refresh follows the General Pharmaceutical Council’s (GPhC) publication of its Standards for Chief Pharmacists (2025). The standards apply across England, Scotland and Wales and aim to strengthen pharmacy governance. RCPharm’s updated guide is designed to support chief pharmacists and directors of pharmacy in meeting the standards as part of their roles. Following consultation with national pharmacy networking groups, the guide covers artificial intelligence, genomics, cyber security, staff governance and wellbeing. It also provides greater information on specialist areas of pharmacy, including mental health and the independent sector. Emily Kennedy, Head of Professional Standards at the Royal College of Pharmacy, said: “The role of the chief pharmacist has changed significantly, and pharmacy leaders are now navigating increasingly complex professional, governance and service demands. This updated guide brings together practical, up-to-date information and resources to help them meet those demands and support safe, effective pharmacy services.” Explore the guide for chief pharmacists or equivalent. Read more news stories.
-
Royal College of Pharmacy welcomes expansion of Pharmacy First Services
Commenting on the Government’s expansion of the NHS Pharmacy First service in England, which will enable patients to receive treatment for five additional conditions through participating community pharmacies, Chair of the Royal College of Pharmacy's English Pharmacy Advisory Council, Professor Mahendra Patel OBE, said: “We welcome the expansion of the NHS Pharmacy First service in England to include treatment for migraines, acne, ear infections, rhinitis and scabies. “The expansion of clinical services not only empowers patients with greater choice on where and how they receive care but also makes the most of the valuable skills of pharmacists and their teams. “It reinforces the value of the clinical expertise that pharmacists bring to patients, communities and the wider NHS, through providing services that are convenient, accessible and trusted by the public. “As Pharmacy First continues to evolve, it is vital that investment in the pharmacy workforce and infrastructure keeps pace with growing demand. The College looks forward to working with the NHS, government and pharmacy teams to ensure patients can continue to benefit from high-quality, clinical care delivered through their local pharmacy.” Read more news stories.
-
Royal College of Pharmacy launches enhanced post-registration standard and credential for newly qualified pharmacist prescribers
The Royal College of Pharmacy (RCPharm) is today (7 September) launching its Enhanced Pharmacist Curriculum and Credentialing Pathway, establishing a nationally recognised professional standard for pharmacists developing their practice after registration as prescribers. The pathway is launched as pharmacist prescribing is integrated into registration, with most newly qualified pharmacists, from 2026, entering practice as independent prescribers and taking on more autonomous clinical responsibilities early in their careers. Developed with a broad range of stakeholders across pharmacy, healthcare, education and patient representatives, the Enhanced Pharmacist Curriculum and Credentialing Pathway supports pharmacists to develop the professional judgement, breadth of experience and confidence needed to manage increasingly complex care safely and effectively. The Enhanced Pharmacist Curriculum and credential provide a nationally recognised pathway from initial registration. It also provides a foundation for continued development through advanced level practice and towards consultant-level practice. It will help pharmacists build confidence, broaden their clinical and prescribing scope and demonstrate capability through workplace-based credentialing – giving employers, partners, patients and the public assurance that pharmacists are developing safely and consistently to deliver high-quality, person-centred care. The curriculum sets outcomes across five domains: person-centred care and collaboration professional practice leadership and management education research and evaluation Through the accompanying national pathways, pharmacists will build a portfolio of evidence from their everyday practice using a new e-portfolio platform developed specifically by the royal college for this purpose. They will be supported by structured learning, supervision, feedback and reflection. Portfolios submitted for credentialing will be independently assessed against the curriculum outcomes by the royal college, providing assurance to pharmacists, employers, patients and the public. Tase Oputu, President of the Royal College of Pharmacy, said: “The introduction of pharmacist prescribing at registration is a defining moment for our profession. Registration provides the foundation, but confidence and professional judgement continue to develop through experience, support and reflection. “The Enhanced Curriculum gives pharmacists and employers a clear, shared standard for that next stage of development and will support pharmacists to deliver safe, high-quality care, while giving employers, the wider health system and patients greater assurance.” Supporting implementation across GB The Enhanced Curriculum and Credentialing pathway provides a shared professional standard across the UK, while training, access and funding arrangements reflect the different national systems. In England, eligible pharmacists will be granted e-portfolio access and supported through NHS England’s commissioned Pharmacist Enhanced Practice Programme pathway. In Scotland, the national pathway will provide eligible pharmacists with structured development and e-portfolio access, with the Enhanced credential positioned as a clear endpoint. In Wales, eligible pharmacists will be supported through the Health Education and Improvement Wales Model of Support, including access to structured development, the e-portfolio and the Enhanced credential as a clear endpoint. The College is also working with employers, education providers and national partners to support consistent implementation and access to appropriate supervision, learning opportunities and protected development time. Joseph Oakley, Associate Director of Assessment & Credentialing at the Royal College of Pharmacy, commented: “A curriculum alone cannot transform practice. Pharmacists also need supportive workplaces, skilled supervisors and collaborators to provide observation and feedback, varied clinical and professional experiences and time and space to develop and build their portfolio. “We are asking employers and system leaders to use our Enhanced Curriculum and Credentialing Pathway as part of their workforce and service-development planning, helping newly qualified pharmacists to translate their registration as prescribers into confident, more autonomous practice.” The Enhanced Curriculum, eligibility information and guidance on national routes are available on the enhanced curriculum and credentialing homepage. Read more news stories.
-
Three RCPharm members take up senior FIP leadership roles
Three members of the Royal College of Pharmacy (RCPharm) have been elected or ratified to senior leadership positions on the Board of the International Pharmaceutical Federation (FIP). Professor Claire Anderson has been elected as a FIP Vice President for 2026–2027, Lars-Åke Söderlund has been elected FIP President-elect for 2026–2027, and Naoko Arakawa has been ratified as FIP Vice President for Operational Education. All three will take up their positions on 3 September, following elections and ratifications by the FIP Council. Former Royal Pharmaceutical Society (RPS) President and current Trustee and Senate member of the RCPharm, Professor Claire Anderson is also a current elected member of the RCPharm English Pharmacy Advisory Council. She served as RPS President from 2021 to 2026 and was nominated by RCPharm for her FIP Vice President role. Lars-Åke will become FIP President from 2027 to 2031, following his term as President-elect. He previously served as a FIP Vice President from 2021 to 2025 and is co-chair of the FIP Technology Advisory Group. Naoko was the International Lead at the RPS for the UK-Japan collaborative programme between 2016 and 2018. She is currently Associate Professor at the School of Pharmacy, University of Nottingham, as well as FIP Interim Education Secretary and a global lead for Competency Development of the FIP Hub. The appointments highlight the depth of expertise and leadership among RCPharm members and their contribution to shaping the future of the profession internationally. Professor Tracey Thornley, a Fellow of RCPharm and former member of the RPS English Pharmacy Board, has also been awarded Fellowship of FIP. RCPharm congratulates Claire, Lars-Åke and Naoko on their appointments, as well as Tracey on her Fellowship. Find out more about FIP. Read more news stories.
-
Pharmacy students must not be left behind as Government expands placement support
The Government has announced that from the start of the 2026/27 academic year, eligible students in England with full access to the NHS Learning Support Fund will be able to receive advance payments towards placement-related travel and accommodation costs. Pharmacy students can currently claim eligible travel and dual accommodation expenses for clinical placements, but do not have full access to the Learning Support Fund. They are not currently eligible for the new advance payment facility, although the Government has said it intends to explore extending the facility to pharmacy students. The Royal College of Pharmacy (RCPharm), alongside the British Pharmaceutical Students’ Association and Pharmacy Schools Council, has previously called on the Government to extend full access to the Learning Support Fund to pharmacy students. Professor Mahendra Patel, Chair of RCPharm’s English Pharmacy Advisory Council, said: “It is disappointing that pharmacy students still do not have full and equal access to the Learning Support Fund. The NHS Long Term Workforce Plan recognised the need to grow the pharmacy workforce, and as pharmacists take on greater clinical and prescribing responsibilities, pharmacy students should have the same access to support as those training for other healthcare professions. “Pharmacy students should not face unjust financial barriers at the very start of their careers. The Government should now build on the progress made so far and ensure pharmacy students have the support they need to train for the future NHS and deliver the care patients need.” Read more news stories.

We are the Royal College of Pharmacy, the professional leadership body for pharmacists and pharmaceutical scientists. We exist to advance the safe and effective use of medicines, drive excellence in patient care and support pharmacists to deliver the highest standards of practice.
As the third largest workforce in healthcare, pharmacy plays a vital role in the health system, and as experts in medicines, pharmacists and their teams are central to patient care and public health. Our mission is to put pharmacy at the forefront of patient care, advancing the safe and effective use of medicines to the benefit of patients and the public.


Have any questions or comments on the new Royal College website?
Please visit our support page or email [email protected]

RCPharm Professional support
One-to-one support – every weekday, 9am until 5pm
Call 0207 572 2737 to speak to a member of our support team, or you can email us using the link below.
Our one-to-one support service is exclusively for RCPharm members.






